STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Revenue growth
+9.5%
XBRL, annual
Net margin
20.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$37.7M
four quarters, 2025-06-01 to 2026-05-31
History
FY Nov 2025
$36.3M
FY Nov 2024
$31.2M
FY Nov 2023
$36.3M
FY Nov 2022
$51.9M
FY Nov 2021
$39.8M
May 2026
$9.4M
Feb 2026
$8.2M
Nov 2025
$9.9M
Aug 2025
$10.3M
May 2025
$8.9M
Feb 2025
$7.2M
Nov 2024
$8.8M
Aug 2024
$8.0M
At each fiscal year end
Single quarter
Net margin, TTM
+3.5%
net income over revenue, 2025-06-01 to 2026-05-31
History
FY Nov 2025
+3.1%
FY Nov 2024
+2.6%
FY Nov 2023
+2.7%
FY Nov 2022
+7.2%
FY Nov 2021
+6.3%
May 2026
+4.3%
Feb 2026
-0.4%
Nov 2025
+4.9%
Aug 2025
+4.6%
May 2025
+1.3%
Feb 2025
+0.8%
Nov 2024
+2.9%
Aug 2024
+5.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.1M
operating cash flow minus capex, 2025-06-01 to 2026-05-31
History
FY Nov 2025
$794.2K
FY Nov 2024
n/a
FY Nov 2023
$2.1M
FY Nov 2022
$2.2M
FY Nov 2021
$2.1M
May 2026
n/a
Feb 2026
n/a
Nov 2025
$727.1K
Aug 2025
$95.8K
May 2025
$101.7K
Feb 2025
-$130.4K
Nov 2024
$868.4K
Aug 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
History
FY Nov 2025
n/a
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
n/a
FY Nov 2021
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
History
FY Nov 2025
n/a
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
n/a
FY Nov 2021
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+6.3%
TTM net income over average of 2025-05-31 and 2026-05-31
History
FY Nov 2025
+5.6%
FY Nov 2024
+4.3%
FY Nov 2023
+5.4%
FY Nov 2022
+24.4%
FY Nov 2021
+21.1%
May 2026
+6.3%
Feb 2026
+5.1%
Nov 2025
+5.6%
Aug 2025
+4.5%
May 2025
+4.5%
Feb 2025
+5.0%
Nov 2024
+4.3%
Aug 2024
+2.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.9%
TTM net income over average of 2025-05-31 and 2026-05-31
History
FY Nov 2025
+4.3%
FY Nov 2024
+3.3%
FY Nov 2023
+3.9%
FY Nov 2022
+16.1%
FY Nov 2021
+12.7%
May 2026
+4.9%
Feb 2026
+4.0%
Nov 2025
+4.3%
Aug 2025
+3.4%
May 2025
+3.4%
Feb 2025
+4.0%
Nov 2024
+3.3%
Aug 2024
+2.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
History
FY Nov 2025
n/a
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
n/a
FY Nov 2021
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+6.9%
operating income (EBIT proxy) over average of 2025-05-31 and 2026-05-31 minus current liabilities
History
FY Nov 2025
+5.9%
FY Nov 2024
+4.5%
FY Nov 2023
+7.9%
FY Nov 2022
+28.5%
FY Nov 2021
+23.4%
May 2026
+6.9%
Feb 2026
+5.2%
Nov 2025
+5.9%
Aug 2025
+5.0%
May 2025
+4.6%
Feb 2025
+4.9%
Nov 2024
+4.5%
Aug 2024
+3.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.39x
close 2026-10-09 over four quarters of diluted EPS, 2025-06-01 to 2026-05-31
History
FY Nov 2025
15.80x
FY Nov 2024
16.07x
FY Nov 2023
15.06x
FY Nov 2022
4.91x
FY Nov 2021
8.47x
May 2026
15.57x
Feb 2026
19.11x
Nov 2025
15.80x
Aug 2025
16.40x
May 2025
14.07x
Feb 2025
14.37x
Nov 2024
16.07x
Aug 2024
25.78x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
History
FY Nov 2025
n/a
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
n/a
FY Nov 2021
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.1%
TTM free cash flow over market value at close 2026-10-09
History
FY Nov 2025
+4.4%
FY Nov 2024
n/a
FY Nov 2023
+15.1%
FY Nov 2022
+12.4%
FY Nov 2021
+10.6%
May 2026
+10.2%
Feb 2026
+10.2%
Nov 2025
+4.4%
Aug 2025
+6.7%
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
+14.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.33x
P/E over trailing EPS growth of 53%: four quarters to 2026-05-31 against the four to 2025-05-31
History
FY Nov 2025
0.37x
FY Nov 2024
n/a
FY Nov 2023
n/a
FY Nov 2022
0.10x
FY Nov 2021
0.13x
May 2026
0.29x
Feb 2026
1.53x
Nov 2025
0.37x
Aug 2025
0.25x
May 2025
0.04x
Feb 2025
0.18x
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-09. Hover a figure to see how it was computed.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
SPRS ranks highest on risk and compliance (97th percentile) and growth (73rd), and lowest on profitability (52nd), among Wholesale & Retail peers.
Profitability
52
Inputs
Return on equity+6.3% · 45 pct, sector of 207
Return on assets+4.9% · 63 pct, sector of 259
Return on invested capitalno debt line filed
Return on capital employed+6.9% · 47 pct, sector of 222
Growth
73
Inputs
Revenue growth, YoY+9.5% · 73 pct, sector of 313
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
97
Inputs
Short interest, % of float+0.0% · 95 pct, sector of 321
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+0.7% · 99 pct, sector of 226
4 not measured: Financial health, Insider conviction, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
No password to create and no card required. We store your email address and nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in. Google Analytics and
Microsoft Clarity load only if you allow them here, to show us which datasets matter.
No ad trackers, ever. Details in the privacy
policy.